Skip to main content
. 2002 Aug 19;99(18):11813–11818. doi: 10.1073/pnas.142417699

Figure 3.

Figure 3

Peptide titration assay with CD8+ T cells from patient 109/ANS immunized with NY-ESO-1 peptides S9C and S11L. PBLs were obtained 85 days after initiation of vaccination. CD8+ T cells were presensitized with L9L and tested on day 11 by CYTOSPOT assay measuring IFN-γ production against T2 cells pulsed with different concentrations of L9L or S11L.